Bivalency as a principle for proteasome inhibition - PubMed (original) (raw)
Bivalency as a principle for proteasome inhibition
G Loidl et al. Proc Natl Acad Sci U S A. 1999.
Abstract
The proteasome, a multicatalytic protease, is known to degrade unfolded polypeptides with low specificity in substrate selection and cleavage pattern. This lack of well-defined substrate specificities makes the design of peptide-based highly selective inhibitors extremely difficult. However, the x-ray structure of the proteasome from Saccharomyces cerevisiae reveals a unique topography of the six active sites in the inner chamber of the protease, which lends itself to strategies of specific multivalent inhibition. Structure-derived active site separation distances were exploited for the design of homo- and heterobivalent inhibitors based on peptide aldehyde head groups and polyoxyethylene as spacer element. Polyoxyethylene was chosen as a flexible, linear, and proteasome-resistant polymer to mimic unfolded polypeptide chains and thus to allow access to the proteolytic chamber. Spacer lengths were selected that satisfy the inter- and intra-ring distances for occupation of the active sites from the S subsites. X-ray analysis of the proteasome/bivalent inhibitor complexes confirmed independent recognition and binding of the inhibitory head groups. Their inhibitory potencies, which are by 2 orders of magnitude enhanced, compared with pegylated monovalent inhibitors, result from the bivalent binding. The principle of multivalency, ubiquitous in nature, has been successfully applied in the past to enhance affinity and avidity of ligands in molecular recognition processes. The present study confirms its utility also for inhibition of multicatalytic protease complexes.
Figures
Figure 1
Schematic representation of the central β-rings of the yeast proteasome with selected distances between active sites as derived from the x-ray structure (13).
Scheme 1
Synthesis of Ac-Arg-Val-Arg-H. (a) i) Z-Arg(Adoc)2-OH, 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate (TBTU)/1-hydroxybenzotriazole/diisopropylethylamine (DIEA), dimethylformamide (DMF); ii) Pd/C (10%), EtOH. (b) i) Ac2O, DIEA, DMF; ii) 95% trifluoroacetic acid.
Scheme 2
Synthesis of the PEG/peptide aldehyde conjugates. (a) 1 equ. H-Leu-Leu-Nle-Sc, TBTU/1-hydroxybenzotriazole (HOBt)/DIEA, DMF. (b) 1 equ. H-Arg(Adoc)2-Val-Arg(Adoc)2-diethyl acetal, TBTU/HOBt/DIEA, DMF. (c) 2 equ. H-Leu-Leu-Nle-Sc, TBTU/HOBt/DIEA, DMF. (d) AcOH, 37% HCHO, MeOH. (e) 95% trifluoroacetic acid.
Figure 2
Part of the x-ray structure of the yeast 20S proteasome/OHC-CO-LGPGGLLnL-H (3) adduct. Protein subunits are marked with different colors: blue for β1, red for β2, yellow for β7, and the inhibitor is shown in white (drawn with
main
; ref. 27).
Figure 3
Part of the electron density map with 2Fo-Fc coefficients after 2-fold averaging of the yeast 20S proteasome/(PEG)19–25-[NH-CO-(CH2)2-CO-Leu-Leu-Nle-H]2 (8) complex. The electron density map was calculated with phases of the free enzyme structure and contoured around the inhibitor molecule at 2ó cutoff. The carbon atoms are marked with different colors: green for β5, red for β6, and white for the inhibitor.
Similar articles
- Synthesis of bivalent inhibitors of eucaryotic proteasomes.
Loidl G, Musiol HJ, Groll M, Huber R, Moroder L. Loidl G, et al. J Pept Sci. 2000 Jan;6(1):36-46. doi: 10.1002/(SICI)1099-1387(200001)6:1<36::AID-PSC232>3.0.CO;2-2. J Pept Sci. 2000. PMID: 10674718 - Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes.
Loidl G, Groll M, Musiol HJ, Ditzel L, Huber R, Moroder L. Loidl G, et al. Chem Biol. 1999 Apr;6(4):197-204. doi: 10.1016/S1074-5521(99)80036-2. Chem Biol. 1999. PMID: 10099130 - Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor.
Groll M, Koguchi Y, Huber R, Kohno J. Groll M, et al. J Mol Biol. 2001 Aug 17;311(3):543-8. doi: 10.1006/jmbi.2001.4869. J Mol Biol. 2001. PMID: 11493007 - Proteasome: a complex protease with a new fold and a distinct mechanism.
Wlodawer A. Wlodawer A. Structure. 1995 May 15;3(5):417-20. doi: 10.1016/S0969-2126(01)00172-1. Structure. 1995. PMID: 7663937 Review. - The proteasome.
Bochtler M, Ditzel L, Groll M, Hartmann C, Huber R. Bochtler M, et al. Annu Rev Biophys Biomol Struct. 1999;28:295-317. doi: 10.1146/annurev.biophys.28.1.295. Annu Rev Biophys Biomol Struct. 1999. PMID: 10410804 Review.
Cited by
- Elucidating the catalytic subunit composition of distinct proteasome subtypes: a crosslinking approach employing bifunctional activity-based probes.
Cornish Carmony K, Sharma LK, Lee DM, Park JE, Lee W, Kim KB. Cornish Carmony K, et al. Chembiochem. 2015 Jan 19;16(2):284-92. doi: 10.1002/cbic.201402491. Epub 2014 Dec 4. Chembiochem. 2015. PMID: 25477005 Free PMC article. - Subunit specific inhibitors of proteasomes and their potential for immunomodulation.
Kisselev AF, Groettrup M. Kisselev AF, et al. Curr Opin Chem Biol. 2014 Dec;23:16-22. doi: 10.1016/j.cbpa.2014.08.012. Epub 2014 Sep 15. Curr Opin Chem Biol. 2014. PMID: 25217863 Free PMC article. Review. - Effects of an anticarcinogenic Bowman-Birk protease inhibitor on purified 20S proteasome and MCF-7 breast cancer cells.
Souza Lda C, Camargo R, Demasi M, Santana JM, de Sá CM, de Freitas SM. Souza Lda C, et al. PLoS One. 2014 Jan 27;9(1):e86600. doi: 10.1371/journal.pone.0086600. eCollection 2014. PLoS One. 2014. PMID: 24475156 Free PMC article. - BU-32: a novel proteasome inhibitor for breast cancer.
Agyin JK, Santhamma B, Nair HB, Roy SS, Tekmal RR. Agyin JK, et al. Breast Cancer Res. 2009;11(5):R74. doi: 10.1186/bcr2411. Breast Cancer Res. 2009. PMID: 19821999 Free PMC article. - Peptide and Peptide-Like Modulators of 20S Proteasome Enzymatic Activity in Cancer Cells.
García-Echeverría C. García-Echeverría C. Int J Pept Res Ther. 2006 Mar;12(1):49-64. doi: 10.1007/s10989-005-9001-4. Epub 2006 Mar 4. Int J Pept Res Ther. 2006. PMID: 19617921 Free PMC article.
References
- Groettrup M, Schmidtke G. DDT. 1999;4:63–71. - PubMed
- Goldberg A L, Stein R, Adams J. Chem Biol. 1995;2:503–508. - PubMed
- Hochstrasser M. Curr Opin Cell Biol. 1995;7:215–223. - PubMed
- Coux O, Tanaka K, Goldberg A L. Annu Rev Biochem. 1996;65:801–847. - PubMed
- Stock D, Nederlof P M, Seemüller E, Baumeister W, Huber R, Löwe J. Curr Opin Biotechnol. 1996;7:376–385. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous